A lab-made compound that helps nerve cells take up more of the building block used to make a memory-related brain messenger. Developed first for Alzheimer's, then depression, it never earned approval. Animal studies show it can repair memory in damaged brains, but human benefits for thinking, vision, and mood rest on personal reports. Long-term safety is unknown. (Full Review)

Protocol

Dose

5–35 mg

1–3× daily, ~20 mg common; start low (~5 mg) and titrate

Choline Co-factor

Pair with choline

e.g., alpha-GPC 300 mg or citicoline 250 mg

Timing & Route

Earlier in day

Split into 2–3 doses; oral with food or sublingual

Time to effect

Memory & Mood

Days to weeks

Builds over repeated dosing, if real

Focus & Vision

30–60 min

Acute subjective effects per dose

Half-life

~3 hours

Short-lived; supports split dosing

Benefits

Low: Restoration of memory in cholinergic-deficit states

Speculative: Cognitive enhancement in healthy adults, mood elevation and anxiety reduction, enhanced visual and color perception, neuroprotection and retinal/optic-nerve support

Contraindications

Pregnancy or breastfeeding

Children and adolescents

Significant cardiac conduction disease (symptomatic bradycardia, high-grade heart block)

Uncontrolled seizure disorders

Active peptic ulcer disease

Key Interactions

Cholinergic drugs (acetylcholinesterase inhibitors: donepezil, rivastigmine, galantamine)

Other cholinergic supplements (alpha-GPC, citicoline/CDP-choline, huperzine A)

Other racetams (piracetam, aniracetam, oxiracetam)

Anticholinergic medications (antihistamines, tricyclic antidepressants, some bladder and Parkinson's drugs)

OTC medications (anticholinergic sleep aids/antihistamines, stimulant products)

Risk & Side Effects

Low: Headache and cholinergic side effects, fatigue and sedation, cognitive dulling

Speculative: Anxiety, irritability, and overstimulation; unknown long-term safety and neuroadaptation; visual disturbances; contaminant and purity-related harm

Monitoring

Marker	Target	Why
Resting heart rate	50–70 bpm	Detects excess cholinergic slowing of the heart
Blood pressure	<120/80 mmHg	Screens cardiovascular tolerability
ALT	<25 U/L	Flags possible liver stress from an unregulated product
AST	<25 U/L	Complements ALT for liver monitoring

Cadence: Baseline before starting, then 2–4 weeks after starting, then every 3–6 months if use continues

Qualitative Assessment

Subjective memory and recall
Focus, attention, and mental clarity
Mood and anxiety levels
Reported visual clarity or color perception
Sleep quality (as a tolerability signal)
Presence or absence of headache and fatigue

Coluracetam for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment